vs
CORCEPT THERAPEUTICS INC（CORT）与Doximity, Inc.（DOCS）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是Doximity, Inc.的1.1倍（$202.1M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs 12.0%，领先21.2%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 9.8%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 17.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
CORT vs DOCS — 直观对比
营收规模更大
CORT
是对方的1.1倍
$185.1M
营收增速更快
CORT
高出1.4%
9.8%
净利率更高
DOCS
高出21.2%
12.0%
两年增速更快
DOCS
近两年复合增速
17.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $185.1M |
| 净利润 | $24.3M | $61.6M |
| 毛利率 | 98.7% | 89.9% |
| 营业利润率 | 2.2% | 38.9% |
| 净利率 | 12.0% | 33.3% |
| 营收同比 | 11.1% | 9.8% |
| 净利润同比 | -21.0% | -18.1% |
| 每股收益（稀释后） | $0.20 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTDOCS
| Q4 25 | $202.1M | $185.1M | ||
| Q3 25 | $207.6M | $168.5M | ||
| Q2 25 | $194.4M | $145.9M | ||
| Q1 25 | $157.2M | $138.3M | ||
| Q4 24 | $181.9M | $168.6M | ||
| Q3 24 | $182.5M | $136.8M | ||
| Q2 24 | $163.8M | $126.7M | ||
| Q1 24 | $146.8M | $118.1M |
净利润CORTDOCS
| Q4 25 | $24.3M | $61.6M | ||
| Q3 25 | $19.7M | $62.1M | ||
| Q2 25 | $35.1M | $53.3M | ||
| Q1 25 | $20.5M | $62.5M | ||
| Q4 24 | $30.7M | $75.2M | ||
| Q3 24 | $47.2M | $44.2M | ||
| Q2 24 | $35.5M | $41.4M | ||
| Q1 24 | $27.8M | $40.6M |
毛利率CORTDOCS
| Q4 25 | 98.7% | 89.9% | ||
| Q3 25 | 97.8% | 90.3% | ||
| Q2 25 | 98.2% | 89.2% | ||
| Q1 25 | 98.5% | 89.5% | ||
| Q4 24 | 98.4% | 91.6% | ||
| Q3 24 | 98.4% | 90.0% | ||
| Q2 24 | 98.5% | 89.3% | ||
| Q1 24 | 98.3% | 89.4% |
营业利润率CORTDOCS
| Q4 25 | 2.2% | 38.9% | ||
| Q3 25 | 4.9% | 37.8% | ||
| Q2 25 | 13.7% | 37.4% | ||
| Q1 25 | 2.2% | 35.2% | ||
| Q4 24 | 13.9% | 47.4% | ||
| Q3 24 | 25.5% | 38.8% | ||
| Q2 24 | 21.7% | 36.4% | ||
| Q1 24 | 20.1% | 35.5% |
净利率CORTDOCS
| Q4 25 | 12.0% | 33.3% | ||
| Q3 25 | 9.5% | 36.8% | ||
| Q2 25 | 18.1% | 36.5% | ||
| Q1 25 | 13.1% | 45.2% | ||
| Q4 24 | 16.9% | 44.6% | ||
| Q3 24 | 25.9% | 32.3% | ||
| Q2 24 | 21.7% | 32.7% | ||
| Q1 24 | 18.9% | 34.4% |
每股收益（稀释后）CORTDOCS
| Q4 25 | $0.20 | $0.31 | ||
| Q3 25 | $0.16 | $0.31 | ||
| Q2 25 | $0.29 | $0.27 | ||
| Q1 25 | $0.17 | $0.31 | ||
| Q4 24 | $0.25 | $0.37 | ||
| Q3 24 | $0.41 | $0.22 | ||
| Q2 24 | $0.32 | $0.21 | ||
| Q1 24 | $0.25 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $64.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $979.3M |
| 总资产 | $836.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTDOCS
| Q4 25 | $372.2M | $64.8M | ||
| Q3 25 | $421.7M | $169.2M | ||
| Q2 25 | $342.2M | $137.3M | ||
| Q1 25 | $322.8M | $209.6M | ||
| Q4 24 | $383.3M | $165.3M | ||
| Q3 24 | $380.3M | $184.2M | ||
| Q2 24 | $473.2M | $111.4M | ||
| Q1 24 | $410.8M | $96.8M |
股东权益CORTDOCS
| Q4 25 | $647.8M | $979.3M | ||
| Q3 25 | $631.9M | $1.1B | ||
| Q2 25 | $635.8M | $1.0B | ||
| Q1 25 | $683.3M | $1.1B | ||
| Q4 24 | $679.6M | $1.0B | ||
| Q3 24 | $638.8M | $961.2M | ||
| Q2 24 | $596.2M | $913.6M | ||
| Q1 24 | $547.9M | $901.4M |
总资产CORTDOCS
| Q4 25 | $836.7M | $1.2B | ||
| Q3 25 | $823.6M | $1.3B | ||
| Q2 25 | $801.7M | $1.2B | ||
| Q1 25 | $846.5M | $1.3B | ||
| Q4 24 | $840.6M | $1.2B | ||
| Q3 24 | $784.3M | $1.1B | ||
| Q2 24 | $714.6M | $1.1B | ||
| Q1 24 | $655.9M | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $60.9M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | 0.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTDOCS
| Q4 25 | $38.4M | $60.9M | ||
| Q3 25 | $54.5M | $93.9M | ||
| Q2 25 | $43.9M | $62.1M | ||
| Q1 25 | $5.1M | $98.5M | ||
| Q4 24 | $59.3M | $65.2M | ||
| Q3 24 | $73.8M | $68.3M | ||
| Q2 24 | $41.2M | $41.2M | ||
| Q1 24 | $23.8M | $63.9M |
自由现金流CORTDOCS
| Q4 25 | $38.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $43.9M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $72.2M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | — | — |
自由现金流率CORTDOCS
| Q4 25 | 19.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 39.5% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | — | — |
资本支出强度CORTDOCS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率CORTDOCS
| Q4 25 | 1.58× | 0.99× | ||
| Q3 25 | 2.77× | 1.51× | ||
| Q2 25 | 1.25× | 1.16× | ||
| Q1 25 | 0.25× | 1.58× | ||
| Q4 24 | 1.93× | 0.87× | ||
| Q3 24 | 1.56× | 1.55× | ||
| Q2 24 | 1.16× | 1.00× | ||
| Q1 24 | 0.86× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
